Allspring Global Investments Holdings, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1890906
CHARLOTTE, NC
Position in REGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$40,561,281
+$11,570,617 QoQ
Shares Held
52,497
+39.8% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 21.776482465664703.ToString("F0")%
Shared 0.ToString("F0")%
None 78.2235175343353.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allspring Global Investments Holdings, LLC holds $702,720,315 across 64 Biotechnology names. REGN ranks #8 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
175,311 | $128,020,857 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,793 | $93,236,848 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,707,715 | $73,243,895 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
889,356 | $66,043,575 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
123,760 | $55,263,790 | |
| 6 | INSM |
INSMED Inc
|
282,734 | $46,232,662 | |
| 7 | ASND |
Ascendis Pharma A/S
|
184,224 | $42,137,554 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
52,497 | $40,561,281 |
All Filings in REGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,561,281 | 52,497 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $28,990,664 | 37,559 | Shares | Other | 2026-01-15 | |
| 2025-09-30 | $15,068,834 | 26,800 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $17,352,825 | 33,053 | Shares | Other | 2025-07-25 | |
| 2025-03-31 | $25,134,533 | 39,630 | Shares | Other | 2025-04-24 | |
| 2024-12-31 | $30,967,833 | 43,474 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $60,047,879 | 57,121 | Shares | Defined | 2024-10-18 | |
| 2024-06-30 | $59,869,820 | 56,963 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $56,033,279 | 58,217 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $45,933,688 | 52,299 | Shares | Defined | 2024-01-25 | |
| 2023-09-30 | $27,929,615 | 33,938 | Shares | Defined | 2023-10-27 | |
| 2023-03-31 | $29,927,686 | 36,423 | Shares | Defined | 2023-04-13 | |
| 2022-12-31 | $28,618,621 | 39,666 | Shares | Defined | 2023-01-23 | |
| 2022-09-30 | $28,198,892 | 40,935 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $44,891,593 | 75,942 | Shares | Defined | 2022-07-25 | |
| 2022-03-31 | $68,300,586 | 97,793 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $61,758,235 | 97,793 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||